Encryption, blockchain, and better user control are transforming EHR systems to keep patient data private, secure, and ...

Results from the Phase III MYR301 trial show that 36% of patients who achieved undetectable hepatitis delta virus levels when ...

Since its launch, Voreifarem has received a strong market response, with trading volumes rapidly increasing and platform ...